B-CELL LYMPHOPROLIFERATIVE DISORDER
Clinical trials for B-CELL LYMPHOPROLIFERATIVE DISORDER explained in plain language.
Never miss a new study
Get alerted when new B-CELL LYMPHOPROLIFERATIVE DISORDER trials appear
Sign up with your email to follow new studies for B-CELL LYMPHOPROLIFERATIVE DISORDER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New immune therapy trial offers hope for Tough-to-Treat blood cancer
Disease control Recruiting nowThis study is testing an experimental drug called epcoritamab in patients with Waldenstrom Macroglobulinemia, a rare blood cancer, who have already tried other treatments. The drug is a type of antibody designed to help the patient's own immune system find and attack cancer cells…
Matched conditions: B-CELL LYMPHOPROLIFERATIVE DISORDER
Phase: PHASE2 • Sponsor: Gottfried von Keudell, MD PhD • Aim: Disease control
Last updated Mar 20, 2026 14:47 UTC
-
New hope for tough blood cancer cases: experimental drug targets relapsed disease
Disease control Recruiting nowThis study is testing whether the drug pacritinib is safe and effective for people with Waldenström macroglobulinemia, a rare blood cancer, that has come back or stopped responding to other treatments. About 30 participants who have had at least two prior treatments will receive …
Matched conditions: B-CELL LYMPHOPROLIFERATIVE DISORDER
Phase: PHASE2 • Sponsor: Shayna Sarosiek, MD • Aim: Disease control
Last updated Mar 09, 2026 14:22 UTC